DIVI'S LABORATORIES LIMITED

Analyst Reco. Divi's Laboratories Limited

Equities

DIVISLAB

INE361B01024

Market Closed - NSE India S.E. Other stock markets 07:40:29 2024-05-21 am EDT			5-day change	1st Jan Change
4,017 ^INR	+2.71%		+2.69%	+2.89%

Apr. 26	Weak March Quarter Earnings Weigh Down Indian Equities on Friday	MT
Apr. 25	Divi's Laboratories Plans Up To INR7 Billion Investment to Boost Capacity	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Jefferies Downgrades Divi’s Laboratories to Hold From Buy, Adjusts Price Target to INR3,510 From INR4,300	Nov. 07	MT
Indian Equities End Higher for Third Time on Monday on Expected Imminent End to Rate Hikes	Nov. 06	MT
Potential US Interest Rate Hikes, Israel-Hamas War Drag Indian Equities to End Lower as Week Ends	23-10-20	MT
Jefferies Adjusts Divi’s Laboratories’ Price Target to INR4,300 From INR3,610, Keeps at Buy	23-08-15	MT
Indian Equities Suffer Solid Losses After US Credit Rating Downgrade	23-08-02	MT
Indian Equities Sink on Thursday After US Fed Raises Interest Rates to Highest in 22 Years	23-07-27	MT
Worries Over Further US Rate Hikes Weigh Down Indian Equities	23-06-22	MT
Jefferies Upgrades Divi’s Laboratories to Buy From Underperform, Adjusts Price Target to INR3,610 From INR 2,550	23-05-22	MT
Worries Over Future Interest Rate Hikes Weigh on Indian Equities	23-02-23	MT
Indian Equities Continue Losing Streak, Weighed Down by Worries Over Future US Rate Hikes	23-02-22	MT
Indian Equities Mirror Weak Asian Peers After Strong US Jobs Data Renew Rate Hikes Fears	23-02-06	MT
Concerns Over Higher Interest Rates in US Scare Indian Equity Investors	22-12-23	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Rankings

More Top / Flop

Rankings

More Top / Flop

Currency / Forex

Commodities

Cryptocurrencies

Cryptocurrencies

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.

BENEFIT NOW